期刊文献+

氟伐他汀对急性脑梗死患者血清抵抗素的影响 被引量:1

Effect of fluvastatin on serum concentration of resistin in patients with acute cerebral infarction
原文传递
导出
摘要 目的观察氟伐他汀对急性脑梗死(ACI)患者血清抵抗素水平的影响及意义。方法 ACI患者78例,分为对照组(42例)和治疗组(36例)。对照组患者给予常规药物治疗2 wk;治疗组患者在常规治疗的基础上加用氟伐他汀40 mg,每日1次,口服,治疗2 wk。所有研究对象均测定治疗前后的高敏C-反应蛋白(hs-CRP)和抵抗素,并评定神经功能缺损程度(NDS)评分。结果与治疗前对比,对照组和治疗组患者治疗后的hs-CRP和抵抗素水平均明显下降(P<0.05),但是治疗组较对照组下降更为显著(P<0.05);对照组和治疗组治疗后的NDS均较治疗前下降,但是治疗组NDS的下降较对照组更为显著(P<0.05)。结论氟伐他汀能降低ACI患者抵抗素水平,并有助于其神经功能的恢复。 AIM To observe the effect and significance of fluvastatin on serum concentration of resistin in patients with acute cerebral infarction(ACI).METHODS Seventy-eight patients with ACI were divided into control group(n = 42) and treatment group(n = 36).Patients in the control group were given conventional medicine treatment for 2 wk,and patients in the treatment group given combined with conventional medicine treatment and oral fluvastatin 40 mg.d-1 for 2 wk.The levels of high sensitivity C-reactive protein(hs-CRP) and resistin were measured with the evaluation of the scores of neurological deficit(NDS) before and after treatment in all patients.RESULTS Comparing to those before the treatment,the serum concentrations of hs-CRP and resistin were obviously reduced after the treatment in both groups(P 0.05),however,reductions of hs-CRP and resistin after the treatment in the treatment group were more apparent than those in the control group(P 0.05).The significant decrease of NDS scores after treatment also occurred in both groups but more reduction was shown in the treatment group(P 0.05).CONCLUSION Fluvastatin can reduce serum concentration of resistin and improve the neurological function in patients with ACI.
作者 陈伟荣
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2010年第6期454-456,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 氟伐他汀 脑梗死 抵抗素 炎症 fluvastatin cerebral infarction resistin inflammation
  • 相关文献

参考文献9

  • 1AMARENCO P, BOGOUSSLAVSKY J, CALLAHAN A, et al.High-dose atorvastatin after stroke or transient ischemic attack [J]. N Engl J Med, 2006, 355(6) : 549-559.
  • 2WANG BW, CHANG H, SHYU KG. Regulation of resistin by cyclic mechanical stretch in cultured rat vascular smooth muscle cells[J]. Clin Sci (Lond), 2009, 118(3): 221-230.
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 4BROWN JP, KATZEL LI, NEUMANN SA, et al. Silent myocardial ischemia and cardiovascular responses to anger provocation in older adults[J]. Int J Behav Med, 2007, 14(3): 134-140.
  • 5CONTI CR. Updated pathophysiologic concepts in unstable coronary artery disease[J]. Am Heart J, 2001, 141 (2 Suppl) : S12-S14.
  • 6曹红,孙长凯,赵耿毅,汪秋艳,刘新胜,许晶,陶定波,唐树良,黄爱莉.C-反应蛋白水平与脑梗死病情及预后的量化研究[J].中国现代神经疾病杂志,2005,5(2):84-87. 被引量:34
  • 7STEPPAN CM, BAILEY ST, BHAT S, et al. The hormone resistin links obesity to diabetes [J]. Nature, 2001, 409(6818): 307-312.
  • 8BOKAREWA M, NAGAEV I, DAHLBERG L, et al. Resistin, an adipokine with potent proinflammatory properties [J]. J Immunol, 2005, 174(9): 5789-5795.
  • 9林玲,罗燕,彭玉兰,周东.彩色多普勒超声对脑梗死患者颈动脉病变的研究[J].中华老年心脑血管病杂志,2005,7(3):175-177. 被引量:31

二级参考文献17

  • 1[3]Dziedzic T, Gryz EA, Turaj W, et al. Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients. J Mol Neurosci, 2004, 24:293-298.
  • 2[4]Silvestri A, Vitale C, Ferretti F, et al. Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke. J Am Geriatr Soc, 2004, 52:1586-1587.
  • 3[5]Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke, 2001, 32:917-924.
  • 4[6]Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke, 1999, 30:981-985.
  • 5[7]Chan Carusone S, Smieja M, Molloy W, et al. Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study. BMC Neurol, 2004, 4:15.
  • 6[8]Van Der Meer IM, De Maat MP, Hak AE, et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke, 2002, 33:2750-2755.
  • 7[9]Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke, 2004, 35:1625-1630.
  • 8[10]Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols: A review of the literature. Altern Med Rev, 2001, 6:248-271.
  • 9[11]Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenona? Circulation, 1999, 100:96-102.
  • 10[12]Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol, 2001, 158:1039-1051.

共引文献33070

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部